Global Intramuscular Drug Delivery Equipment Market Size By Type (Molecular Structures, Polymers), By Application (Infectious Disease, Oncology), By Region, And Segment Forecasts, 2023 to 2032

The Global Intramuscular Drug Delivery Equipment Market was valued at USD 12.1 billion in 2023 and is projected to reach USD 19.4 billion by 2031, growing at a CAGR of 6.1% during the forecast period from 2023 to 2031. The growth of this market is fueled by the rising prevalence of chronic and infectious diseases, increased demand for fast-acting drug delivery methods, and the growing adoption of self-administration devices for injectable drugs.

Intramuscular drug delivery offers a rapid and efficient route for systemic drug absorption and is widely utilized for administering vaccines, hormonal therapies, and pain management drugs. The market is evolving with technological advancements in auto-injectors and safety syringes, which enhance ease of use and patient compliance.

Drivers

1. Increasing Prevalence of Chronic and Infectious Diseases

The growing global burden of diseases such as diabetes, cancer, and respiratory infections is driving demand for intramuscular drug delivery systems, especially for long-term therapies that require consistent dosing.

2. Technological Advancements in Drug Delivery Devices

Innovations such as smart injectors, needle-free devices, and electronic autoinjectors are increasing safety, accuracy, and convenience, contributing to the rapid adoption of intramuscular delivery equipment.

3. Demand for Emergency Medication Delivery

Intramuscular delivery is critical for emergencies requiring rapid drug absorption, such as anaphylaxis and opioid overdose, boosting the market for auto-injectors and prefilled syringes.

Restraints

1. Pain and Discomfort Associated with Intramuscular Injections

Despite its efficacy, intramuscular injection can cause pain, swelling, and tissue damage, potentially discouraging patients from adhering to treatment regimens.

2. Availability of Alternative Drug Delivery Routes

Oral, transdermal, and subcutaneous routes offer competitive advantages in some therapeutic scenarios, limiting the use of intramuscular equipment.

Opportunity

1. Growing Home Healthcare and Self-Administration Trends

With a rising preference for home-based care, the demand for user-friendly and safe intramuscular drug delivery devices is expanding, especially among geriatric and chronic disease populations.

2. Expanding Vaccine and Biologic Markets

Global immunization programs and increasing investment in biologics, including mRNA-based therapies, present significant growth potential for intramuscular delivery systems.

Market by System Type Insights

The Auto-Injectors segment dominated the market in 2023 due to its enhanced safety, convenience, and widespread use in self-administered therapies. This segment is expected to maintain its lead through 2031, driven by the increasing demand for emergency medication delivery and chronic disease management.

The Safety Syringes segment is also witnessing substantial growth as healthcare regulations increasingly mandate safety-enhanced devices to prevent needlestick injuries and ensure dosage precision.

Market by End-use Insights

In 2023, the Hospitals & Clinics segment accounted for the largest market share, driven by the high volume of injectable therapies administered in clinical settings. However, the Homecare segment is projected to witness the fastest growth, supported by the trend toward decentralized healthcare and increasing patient empowerment.

Market by Regional Insights

North America led the global market in 2023, accounting for the largest share due to robust healthcare infrastructure, high prevalence of chronic conditions, and advanced medical technologies.

Asia-Pacific is expected to be the fastest-growing region, owing to expanding healthcare access, increasing vaccination drives, and rising awareness about disease prevention and management in countries such as India and China.

Competitive Scenario

Key players in the Global Intramuscular Drug Delivery Equipment Market include:

Becton, Dickinson and Company

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Eli Lilly and Company

GlaxoSmithKline plc

AstraZeneca

Bayer AG

Novartis AG

Merck & Co., Inc.

Sanofi S.A.

These companies are actively investing in product innovation, strategic partnerships, and regional expansion to maintain a competitive edge.

Key Developments:

In 2023, BD launched a new range of prefilled auto-injectors with built-in tracking for real-time dose monitoring.

In 2024, Pfizer expanded its production capacity for injectable biologics, targeting markets in Latin America and Southeast Asia.

In 2025, Teva partnered with a digital health startup to develop a smart intramuscular injector designed for real-time patient data logging.

Scope of Work – Global Intramuscular Drug Delivery Equipment Market

Report Metric Details

Market Size (2023) USD 12.1 billion

Projected Market Size (2031) USD 19.4 billion

CAGR (2023–2031) 6.1%

Market Segments By System Type (Auto-Injectors, Safety Syringes, Prefilled Syringes), By End-use (Hospitals & Clinics, Homecare, Ambulatory Surgical Centers), By Region

Growth Drivers Rising chronic disease burden, technological innovations, increased home healthcare adoption

Opportunities Growth in biologics, expanding vaccine programs, smart drug delivery technologies

FAQs

1. What is the current market size of the Global Intramuscular Drug Delivery Equipment Market?

The market size was valued at USD 12.1 billion in 2023.

2. What is the major growth driver of the Global Intramuscular Drug Delivery Equipment Market?

The primary growth driver is the increasing prevalence of chronic diseases and the rising adoption of self-administered drug delivery devices.

3. Which is the largest region during the forecast period in the Global Intramuscular Drug Delivery Equipment Market?

North America holds the largest share, while Asia-Pacific is expected to witness the fastest growth.

4. Which segment accounted for the largest market share in Global Intramuscular Drug Delivery Equipment Market?

The Auto-Injectors segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Intramuscular Drug Delivery Equipment Market?

Key players include Becton, Dickinson and Company, Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline plc, and AstraZeneca.

Let me know if you want this formatted for a webpage or exported to Word or PDF!